Pharmacotherapy (Record no. 29786)

MARC details
000 -LEADER
fixed length control field 04500nam a22003497a 4500
001 - CONTROL NUMBER
control field 20241111094026.0
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241111094604.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241111b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0-07-164325-7
International Standard Book Number 0-07-147899-X.
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
100 ## - MAIN ENTRY--PERSONAL NAME
Fuller form of name Joseph T. DiPiro
222 ## - KEY TITLE
Key title Pharmacotherapy A Pathophysiologic Approach
Qualifying information ACE inhibitors activity acute administration agents aldosterone amiodarone angina angiotensin antiarrhythmic anticoagulation antihypertensive ARB arrhythmias aspirin assessment associated atrial fibrillation bivalirudin bleeding blood flow blood pressure BP calcium channel blocker Cardiol Cardiovascular Disorders cause Chapter cholesterol chronic Clin clinical trials clopidogrel contraindications coronary artery disease creatinine decrease diabetes diastolic digoxin diltiazem diuretic dosage dose drug therapy dysfunction ECG Engl enoxaparin enzyme evaluation fondaparinux function gene guidelines heart disease heart failure heart rate hemodynamic heparin hospital hypertension hypotension increased infusion initial INR intravenous ischemia ischemic LDL left ventricular LMWH LV metabolism mg monitoring mortality myocardial infarction oral outcomes patients PCI pediatric pharmacokinetic pharmacologic Pharmacotherapy Pharmacy PharmD platelet poisoning prevention protein pulmonary receptor recommended reduced renal result rhythm risk factors SECTION 2 Cardiovascular sinus sodium ẞ-blockers stroke studies symptoms syndrome systolic Table tachycardia therapeutic thromboembolism thrombosis tion tissue toxicity treatment UFH vascular vasodilation venous verapamil VTE warfarin
240 ## - UNIFORM TITLE
Uniform title Pharmacotherapy.
245 ## - TITLE STATEMENT
Title Pharmacotherapy
Remainder of title A Pathophysiologic Approach.
246 ## - VARYING FORM OF TITLE
Title proper/short title Pharmacotherapy.
247 ## - FORMER TITLE
Title Pharmacotherapy.
250 ## - EDITION STATEMENT
Edition statement 7th. Edition
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Philadelphia |
Name of publisher, distributor, etc. The McGraw-Hill Companies, Inc |
Date of publication, distribution, etc. 2008
300 ## - PHYSICAL DESCRIPTION
Extent 2597 Pagges
Extent Includes Index
520 ## - SUMMARY, ETC.
Summary, etc. Job: Dipiro et al.: Pharmacotherapy: A Pathophysiologic Approach, 7e back cover copy; 9780071478991; 007147899X<br/><br/>[title]<br/><br/>Pharmacotherapy:<br/><br/>A Pathophysiologic Approach<br/><br/>Seventh Edition<br/><br/>[authors]<br/><br/>Joseph T. DiPiro<br/><br/>Robert L. Talbert<br/><br/>Gary C. Yee<br/><br/>Gary R. Matzke<br/><br/>Barbara G. Wells<br/><br/>L. Michael Posey<br/><br/>[Burst:]<br/><br/>Additional Chapters Available Online!<br/><br/>[headline]<br/><br/>The benchmark evidence-based pharmacotherapy text-now in full color!<br/><br/>When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach. Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs.<br/><br/>The book also delves into psychosocial issues that affect compliance ... topics related to a patient's ability to understand and manage often-complex therapy... and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes. Pharmacotherapy delivers everything you need to provide safe, efficacious drug therapy across the full range of therapeutic categories.<br/><br/>FEATURES<br/><br/>NEW! Expanded evidence-based recommendations NEW! Extended coverage of the timely issue of palliative care and pain medicine NEW! Important chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorus Homeostasis, and Multiple Myeloma, Outstanding pedagogy, including: “Key Concepts” highlighted in each chapter “Clinical Presentation” boxes summarize the most common disease signs and symptoms covered in each chapter “Clinical Controversies” boxes-presented in the Treatment sections of the disease-oriented chapters-examine the complicated issues faced by students and clinicians in providing drug therapy Clear therapeutic recommendations in each disease-specific chapter “Evaluation of Therapeutic Outcomes” boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan<br/>[McGraw-Hill Medical logo]
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Pharmacy, Medical / Chemotherapy, Medical / Pathophysiology, Chemotherapy, Physiology, Pathological
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Robert L. Talbert
Fuller form of name Gary C. Yee
Fuller form of name Gary R. Matzke
Fuller form of name Barbara G. Wells
Fuller form of name L. Michael Posey ·
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Copy number Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 11/11/2024   20241111094026.0 11/11/2024 20241111094026.0 11/11/2024 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024